{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:52:12Z","timestamp":1792803132049,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"American Society of Clinical Oncologists Young Investigator Award","id":[{"id":"https:\/\/ror.org\/04fy6j421","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institutes of Health Program in Cancer Outcomes Research Training","award":["R25CA092203"],"award-info":[{"award-number":["R25CA092203"]}]},{"name":"Dana-Farber Cancer Institute Gastrointestinal SPORE Career Development Award","award":["5P50CA127003\u201305"],"award-info":[{"award-number":["5P50CA127003\u201305"]}],"id":[{"id":"https:\/\/ror.org\/02xjhr934","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>The Cancer-Specific Geriatric Assessment (CSGA) is a primarily self-administered paper survey of validated measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We developed and tested the feasibility of a computer-based CSGA in patients \u226570 years of age who were receiving treatment for gastrointestinal malignancies at the Dana-Farber Cancer Institute. From December 2009 to June 2011, patients were invited to complete the CSGA at baseline (start of new treatment) and follow-up (at the first of 4 months later or within 4 weeks of completing treatment). Feasibility endpoints were proportion of eligible patients consented, proportion completing CSGA at baseline and follow-up, time to complete CSGA, and proportion of physicians reporting CSGA results that led to a change in clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Of the 49 eligible patients, 38 consented (76% were treatment naive). Median age was 77 years (range: 70\u201389 years), and 48% were diagnosed with colorectal cancer. Mean physician-rated Karnofsky Performance Status was 87.5 at baseline (SD 8.4) and 83.5 at follow-up (SD 8). At baseline, 92% used a touchscreen computer; 97% completed the CSGA (51% independently). At follow-up, all patients used a touchscreen computer; 71% completed the CSGA (41% independently). Mean time to completion was 23 minutes at baseline (SD 8.4) and 20 minutes at follow-up (SD 5.1). The CSGA added information to clinical assessment for 75% at baseline (n = 27) and 65% at follow-up (n = 17), but it did not alter immediate clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion.<\/jats:title>\n                    <jats:p>The computer-based CSGA feasibility endpoints were met, although approximately half of patients required assistance. The CSGA added information to clinical assessment but did not affect clinical decision-making, possibly due to limited alternate treatment options in this subset of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1634\/theoncologist.2012-0241","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T00:42:22Z","timestamp":1357260142000},"page":"64-72","source":"Crossref","is-referenced-by-count":82,"title":["Feasibility of Computer-Based Self-Administered Cancer-Specific Geriatric Assessment in Older Patients With Gastrointestinal Malignancy"],"prefix":"10.1093","volume":"18","author":[{"given":"Nadine J.","family":"McCleary","sequence":"first","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Wigler","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Berry","sequence":"additional","affiliation":[{"name":"b Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Sato","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Abrams","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Chan","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Enzinger","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmie","family":"Ng","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Wolpin","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Schrag","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Fuchs","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Hurria","sequence":"additional","affiliation":[{"name":"c Department of Medical Oncology, Cancer and Aging Research Program, City of Hope, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Meyerhardt","sequence":"additional","affiliation":[{"name":"a Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"key":"2021122308322696000_B1","volume-title":"Cancer Facts & Figures 2007","year":"2007"},{"key":"2021122308322696000_B2","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiac and pulmonary late effects","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"key":"2021122308322696000_B3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.critrevonc.2006.06.003","article-title":"The older cancer survivor","volume":"60","author":"Rao","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"2021122308322696000_B4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jnci\/djj154","article-title":"Cancer survivorship: The interface of aging, comorbidity, and quality care","volume":"98","author":"Rowland","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2021122308322696000_B5","volume-title":"Surveillance Epidemiology and End Results","author":"SEER","year":"2011"},{"key":"2021122308322696000_B6","first-page":"18","article-title":"Greater risks of chemotherapy toxicity in elderly patients with cancer","volume":"1","author":"Repetto","year":"2003","journal-title":"J Support Oncol"},{"key":"2021122308322696000_B7","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.critrevonc.2003.06.001","article-title":"Supportive care of the older cancer patient","volume":"48","author":"Balducci","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"2021122308322696000_B8","first-page":"135","article-title":"Management of cancer in the elderly","volume":"20","author":"Balducci","journal-title":"Oncology"},{"key":"2021122308322696000_B9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1040-8428(03)00024-6","article-title":"Prevention and therapy of neutropenia in elderly patients","volume":"46","author":"Rosti","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"2021122308322696000_B10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1040-8428(00)00049-4","article-title":"Advances in the systemic treatment of cancers in the elderly","volume":"35","author":"Carbone","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"key":"2021122308322696000_B11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.seminoncol.2003.12.027","article-title":"Chemotherapy in the elderly","volume":"31","author":"Lichtman","year":"2004","journal-title":"Semin Oncol"},{"key":"2021122308322696000_B12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00432-007-0233-x","article-title":"Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients","volume":"133","author":"Wedding","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"2021122308322696000_B13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1040-8428(00)00130-X","article-title":"Prevalence of functional disability among elderly patients with cancer","volume":"39","author":"Serraino","year":"2001","journal-title":"Crit Rev Oncol Hematol"},{"key":"2021122308322696000_B14","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1200\/JCO.1998.16.4.1582","article-title":"Comorbidity and functional status are independent in older cancer patients","volume":"16","author":"Extermann","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021122308322696000_B15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.7326\/0003-4819-145-9-200611070-00006","article-title":"The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: Implications for screening","volume":"145","author":"Gross","year":"2006","journal-title":"Ann Intern Med"},{"key":"2021122308322696000_B16","first-page":"597","article-title":"Management of advanced colorectal cancer in older patients","volume":"19","author":"Lichtman","year":"2005","journal-title":"Oncology"},{"key":"2021122308322696000_B17","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cncr.21422","article-title":"Developing a cancer-specific geriatric assessment: A feasibility study","volume":"104","author":"Hurria","year":"2005","journal-title":"Cancer"},{"key":"2021122308322696000_B18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/107327480701400102","article-title":"Aging, frailty, and chemotherapy","volume":"14","author":"Balducci","year":"2007","journal-title":"Cancer Control"},{"key":"2021122308322696000_B19","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","article-title":"Comprehensive geriatric assessment for older patients with cancer","volume":"25","author":"Extermann","year":"2007","journal-title":"J Clin Oncol"},{"key":"2021122308322696000_B20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.2002.20.2.494","article-title":"Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: An Italian Group for Geriatric Oncology Study","volume":"20","author":"Repetto","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122308322696000_B21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.critrevonc.2006.03.007","article-title":"Geriatric assessment for oncologists: Rationale and future directions","volume":"59","author":"Hurria","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"2021122308322696000_B22","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"2021122308322696000_B23","first-page":"271","article-title":"Prospective value of self-report and performance-based tests of functional status for 18-month outcomes in elderly patients","volume":"8","author":"Nikolaus","year":"1996","journal-title":"Aging"},{"key":"2021122308322696000_B24","doi-asserted-by":"crossref","first-page":"M106","DOI":"10.1093\/geronj\/47.4.M106","article-title":"The predictive validity of self-report and performance-based measures of function and health","volume":"47","author":"Reuben","year":"1992","journal-title":"J Gerontol"},{"key":"2021122308322696000_B25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/jech.54.2.123","article-title":"The predictive value of self assessed general, physical, and mental health on functional decline and mortality in older adults","volume":"54","author":"Lee","year":"2000","journal-title":"J Epidemiol Community Health"},{"key":"2021122308322696000_B26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2466\/pms.1996.82.2.689","article-title":"Assessing functional status of elderly adults via microcomputer","volume":"82","author":"Yarnold","year":"1996","journal-title":"Percept Mot Skills"},{"key":"2021122308322696000_B27","first-page":"295","article-title":"Quality of life assessment software for computer-inexperienced older adults: multimedia utility elicitation for activities of daily living","author":"Goldstein","year":"2002","journal-title":"Proc AMIA Symp"},{"key":"2021122308322696000_B28","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1200\/JCO.2010.30.6985","article-title":"Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"2021122308322696000_B29","first-page":"30","article-title":"New paradigms for treating elderly patients with cancer: The comprehensive geriatric assessment and guidelines for supportive care","volume":"1","author":"Balducci","year":"2003","journal-title":"J Support Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2012-0241","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2012-0241","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/1\/64\/41856233\/oncolo_18_1_64.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/1\/64\/41856233\/oncolo_18_1_64.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:11:01Z","timestamp":1640283061000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/18\/1\/64\/6410168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,3]]},"published-print":{"date-parts":[[2013,1,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2012-0241","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,1,1]]},"published":{"date-parts":[[2013,1,1]]}}}